WebJul 27, 2024 · GAINESVILLE, Fla.-- ( BUSINESS WIRE )-- Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing... WebRecently Viewed Tickers Overview Profile Charts Financials Historical Quotes Analyst Estimates Options Snapshot Stock Price Targets Yearly Numbers Estimates CYTH will report 2024 earnings on...
CYTH Cyclo Therapeutics Inc. Analyst Estimates MarketWatch
WebCyclo Therapeutics Shares Outstanding 2010-2024 CYTH Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding Cyclo Therapeutics shares outstanding from 2010 to 2024. WebCyclo Therapeutics Inc. analyst estimates, including CYTH earnings per share estimates and analyst recommendations. how to slow cancer
Search Results - Boards InvestorsHub
WebMar 8, 2024 · Ticker: CYTH CIK: 922247 Form Type: 8-K Corporate News Accession Number: 0001437749-23-005797 Submitted to the SEC: Wed Mar 08 2024 4:05:30 PM EST Accepted by the SEC: Wed Mar 08 2024 Period: Friday, March 3, 2024 Industry: Industrial Organic Chemicals Events: Bylaw Change; Financial Exhibit; Vote of Security Holders; WebInsider trades for Cyclo Therapeutics, Inc. (CYTH). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. ... Ticker Insider Name Title Trade Type Price Qty Owned ΔOwn Value 1d 1w 1m 6m; 2024-09-22 10:01:48. 2024-09-21. CYTH: Ostronic Francis Patrick: Dir: P - Purchase: $1.76 ... WebCyclo Therapeutics shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares. how to slow bile production